Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency

计划入组 7 人 · 首次发布于 2019 年 1 月 4 日

Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency

计划入组 16 人 · 首次发布于 2014 年 3 月 21 日

Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

计划入组 67 人 · 首次发布于 2014 年 2 月 19 日

Fibrinogen human(Artiss, Evarrest, Evicel, Fibryga, Riastap, Tachosil, Tisseel, Vistaseal, TachoSil)

Rx

porcine-derived fibrinogen

congenital hyperinsulinism therapeutic

Rockwell Medical

United States

VentriPoint Diagnostics Ltd

Ai-Media Technologies Ltd

United States

FDA Approves Grifols' Fesilty for Congenital Fibrinogen Deficiency Treatment

Grifols Launches FESILTY™ Fibrinogen Concentrate in the U.S. for Congenital Fibrinogen Deficiency

Grifols' Biotest Achieves Phase 3 Success for Fibrinogen Concentrate in Acquired Deficiency Treatment